DWA
LBPH

Dorsey Wright & Associates’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Dorsey Wright & Associates’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,045
Closed -$16.9K – 309
2023
Q3 		$16.9K Sell
3,045
-105
-3% -$676 0.01% 277
2023
Q2 		$23.1K Buy
+3,150
New +$23.8K 0.01% 231

Other funds holding LBPH

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dorsey Wright & Associates's LBPH Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2023, closing a stake of 3,045 shares — an estimated $16.9K sold.

Dorsey Wright & Associates first reported a position in LBPH in Q2 2023 and held it in 2 quarters. The position peaked at $23.1K in Q2 2023. 52 funds tracked by Wall St. Rank hold LBPH as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,045 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $16.9K.
  • Dorsey Wright & Associates first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Dorsey Wright & Associates's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $23.1K in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.